A. G. Amiryan
Research Subjects
A. G. Amiryan has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Svetlana V. Saakyan
Helmholtz National Medical Research Center of Eye Diseases
5 shared publications - Aleksandr Yu. Tsygankov
Helmholtz National Medical Research Center of Eye Diseases; Russian University of Medicine
3 shared publications A. A. Zharov
Helmholtz National Medical Research Center of Eye Diseases
1 shared publication- Dmitrii A. Khochenkov
Institute of Experimental Diagnostics and Treatment of Cancer N.N. Blokhin Cancer Research Center Moscow Russia
1 shared publication - E. S. Sorozhkina
Helmholtz National Medical Research Center of Eye Diseases
1 shared publication - Galina Zakharova
Saint Petersburg Research Institute of Ear, Throat, Nose and Speech
1 shared publication
Latest Publications
- 16 October 2026
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 142 (5)
Features of local and systemic production of major immune response cytokines in epithelial lacrimal gland tumors
Investigation of the cytokine profile in tear fluid (TF) as a local environment, as well as in blood serum (BS), which reflects systemic immune status, may provide valuable information on the pathogenetic features and biological behavior of epithelial lacrimal gland tumors (LGTs). Objective. The study aimed to investigate changes in the levels of key cytokines associated with the immune response (IL-6, TNF-α, IL-2, IFN-γ, IL-17A, IL-4, IL-10) in TF and BS of patients with epithelial LGTs. Material and methods. The study examined 21 participants, including 10 healthy volunteers and 11 patients with epithelial LGTs (pleomorphic adenoma (PA) was diagnosed in 6 cases and lacrimal gland cancer (LGC) — in 5 cases). Cytokine levels in test samples were determined by multiplex analysis (CBA platform) using a flow cytometer. The analysis accounted for both the concentration of immunomediators and the frequency of their detection in the tested material. Results. Patients with PA and LGC showed changes in both the qualitative and quantitative composition of proinflammatory and anti-inflammatory mediators. In TF of patients with LGC, the highest concentrations of IL-6, TNF-α, IL-17A, and IL-10 were observed, mainly on the affected side. Patients with PA also showed elevated levels of IL-6, TNF-α, and IL-17A compared with the corresponding control values, but cytokine activation was less pronounced than in LGC. The analysis showed that assessment of TNF-α levels in TF is the most promising diagnostic marker of LGC: elevated concentrations of this cytokine were detected on the tumor side in all patients and were almost 20-fold higher than in PA (p<0.05 when comparing LGC patients with controls and the tumor side in LGC with PA). In BS the differences between the groups were less pronounced and not indicative. Conclusion. The obtained data allow the local cytokine profile to be considered as an additional noninvasive tool for differential diagnosis between benign and malignant epithelial LGTs.
- 16 October 2026
- Published by Media Sphere Publishing Group in Russian Annals of Ophthalmology
- Vol. 142 (5)
Features of local and systemic production of major immune response cytokines in epithelial lacrimal gland tumors
Investigation of the cytokine profile in tear fluid (TF) as a local environment, as well as in blood serum (BS), which reflects systemic immune status, may provide valuable information on the pathogenetic features and biological behavior of epithelial lacrimal gland tumors (LGTs). Objective. The study aimed to investigate changes in the levels of key cytokines associated with the immune response (IL-6, TNF-α, IL-2, IFN-γ, IL-17A, IL-4, IL-10) in TF and BS of patients with epithelial LGTs. Material and methods. The study examined 21 participants, including 10 healthy volunteers and 11 patients with epithelial LGTs (pleomorphic adenoma (PA) was diagnosed in 6 cases and lacrimal gland cancer (LGC) — in 5 cases). Cytokine levels in test samples were determined by multiplex analysis (CBA platform) using a flow cytometer. The analysis accounted for both the concentration of immunomediators and the frequency of their detection in the tested material. Results. Patients with PA and LGC showed changes in both the qualitative and quantitative composition of proinflammatory and anti-inflammatory mediators. In TF of patients with LGC, the highest concentrations of IL-6, TNF-α, IL-17A, and IL-10 were observed, mainly on the affected side. Patients with PA also showed elevated levels of IL-6, TNF-α, and IL-17A compared with the corresponding control values, but cytokine activation was less pronounced than in LGC. The analysis showed that assessment of TNF-α levels in TF is the most promising diagnostic marker of LGC: elevated concentrations of this cytokine were detected on the tumor side in all patients and were almost 20-fold higher than in PA (p<0.05 when comparing LGC patients with controls and the tumor side in LGC with PA). In BS the differences between the groups were less pronounced and not indicative. Conclusion. The obtained data allow the local cytokine profile to be considered as an additional noninvasive tool for differential diagnosis between benign and malignant epithelial LGTs.
- 5 April 2026
- Published by Real Time, Ltd. in Russian Ophthalmological Journal
- Vol. 19 (1)
Primary orbital melanoma. A case series
Purpose. Retrospective analysis of clinical, instrumental and pathomorphologic features of primary orbital melanoma based on our own observations between 2007 and 2024. Materials and methods. 6 cases of primary melanoma of the orbit were examined and treated at the Department of Ophthalmic Oncology and Radiology of the Helmholtz Medical Center of the Russian Ministry of Health. The age of the patients at the time of diagnosis ranged from 18 to 65 years (mean — 48.0 ± 17.6 years). 2 patients had oculodermal melanosis. The clinical course of the disease at the stages of dynamic follow-up of the patients and the peculiarities of vital prognosis taking into account the management tactics and pathomorphological features of the tumor were evaluated. Results. The duration of the history varied from 3 months to 3 years. The main clinical signs included exophthalmos (n = 6), restricted eye movement (n = 4) and partial ptosis (n = 3). The development of metastatic disease occurred in 3 of 6 patients: to the lungs, liver, and brain in 12, 18, and 48 months after the start of treatment, respectively. Epithelioid and mixed cell type tumors with high number of mitotic cells, congenital melanosis were the indicators of unfavorable prognosis. Life expectancy was higher in patients who underwent remote irradiation after tumor removal. Conclusions. Primary orbital melanoma is a rare, aggressive orbital tumor that does not have specific clinical and instrumental symptoms, which complicates the diagnosis and simulates a benign orbital tumor. It is necessary to be alert to the development of this pathology in patients with primary oculodermal melanosis, which requires lifelong dynamic monitoring. The vital prognosis of patients is influenced by both the histological type of the tumor and early radiation therapy after surgical treatment. For a better understanding of the pathogenesis of the disease, it is necessary to consolidate and conduct multicenter studies with the study of the genetic profile of the disease to subsequently search for and develop optimal therapy.
- 5 April 2026
- Published by Real Time, Ltd. in Russian Ophthalmological Journal
- Vol. 19 (1)
Primary orbital melanoma. A case series
Purpose. Retrospective analysis of clinical, instrumental and pathomorphologic features of primary orbital melanoma based on our own observations between 2007 and 2024. Materials and methods. 6 cases of primary melanoma of the orbit were examined and treated at the Department of Ophthalmic Oncology and Radiology of the Helmholtz Medical Center of the Russian Ministry of Health. The age of the patients at the time of diagnosis ranged from 18 to 65 years (mean — 48.0 ± 17.6 years). 2 patients had oculodermal melanosis. The clinical course of the disease at the stages of dynamic follow-up of the patients and the peculiarities of vital prognosis taking into account the management tactics and pathomorphological features of the tumor were evaluated. Results. The duration of the history varied from 3 months to 3 years. The main clinical signs included exophthalmos (n = 6), restricted eye movement (n = 4) and partial ptosis (n = 3). The development of metastatic disease occurred in 3 of 6 patients: to the lungs, liver, and brain in 12, 18, and 48 months after the start of treatment, respectively. Epithelioid and mixed cell type tumors with high number of mitotic cells, congenital melanosis were the indicators of unfavorable prognosis. Life expectancy was higher in patients who underwent remote irradiation after tumor removal. Conclusions. Primary orbital melanoma is a rare, aggressive orbital tumor that does not have specific clinical and instrumental symptoms, which complicates the diagnosis and simulates a benign orbital tumor. It is necessary to be alert to the development of this pathology in patients with primary oculodermal melanosis, which requires lifelong dynamic monitoring. The vital prognosis of patients is influenced by both the histological type of the tumor and early radiation therapy after surgical treatment. For a better understanding of the pathogenesis of the disease, it is necessary to consolidate and conduct multicenter studies with the study of the genetic profile of the disease to subsequently search for and develop optimal therapy.
- Open Access
- 9 January 2026
- Published by Real Time, Ltd. in Russian Ophthalmological Journal
- Vol. 18 (4) , 113-119
Alpha-2-macroglobulin in tear fluid: a step in diagnosis of lacrimal gland tumors
The purpose of the work was to study the activity of the acute phase inflammation protein alpha-2-macroglobulin (α2-MG) in the tear fluid (TF) of patients with different morphological variants of lacrimal gland tumors (LGT). Material and methods. The study included 33 patients with morphologically verified diagnosis of LGT. The control group (healthy individuals) was additionally recruited for comparative evaluation. TF was collected from both eyes before surgery using filter paper. The activity of α2-MG was determined by enzymatic method. Results. It was revealed that in epithelial tumors of the LG — pleomorphic adenoma and lacrimal gland carcinoma, there was an increase of α2-MG activity in the TF on the side of the lesion compared to the control group. At the same time, in 67 % (n = 4) of LG carcinoma cases there was a tendency to increase α2-MG activity also on the healthy side. In LG lymphomas, no significant differences from the norm in α2-MG activity in the TF both on the tumor side and on the healthy side could be detected. The α2-MG activity did not depend on the tumor volume and clinical features. In patients with LG carcinoma with a history of more than 10 months, high values of α2-MG activity in the TF on the contralateral healthy side were detected. Conclusion. For the first time we evaluated the activity of α2-MG protein in the TF and showed characteristic features in different morphologic variants of LGT. The search for biochemical markers in TF opens new opportunities for studying the pathogenesis of this category tumors, which may contribute to the development of personalized therapy. The obtained data allow to improve diagnostics of LGT and can be applied in clinical practice in the system of complex diagnostics at the stage of preoperative preparation.
- 9 January 2026
- Published by Real Time, Ltd. in Russian Ophthalmological Journal
- Vol. 18 (4) , 113-119
Open AccessAlpha-2-macroglobulin in tear fluid: a step in diagnosis of lacrimal gland tumors
The purpose of the work was to study the activity of the acute phase inflammation protein alpha-2-macroglobulin (α2-MG) in the tear fluid (TF) of patients with different morphological variants of lacrimal gland tumors (LGT). Material and methods. The study included 33 patients with morphologically verified diagnosis of LGT. The control group (healthy individuals) was additionally recruited for comparative evaluation. TF was collected from both eyes before surgery using filter paper. The activity of α2-MG was determined by enzymatic method. Results. It was revealed that in epithelial tumors of the LG — pleomorphic adenoma and lacrimal gland carcinoma, there was an increase of α2-MG activity in the TF on the side of the lesion compared to the control group. At the same time, in 67 % (n = 4) of LG carcinoma cases there was a tendency to increase α2-MG activity also on the healthy side. In LG lymphomas, no significant differences from the norm in α2-MG activity in the TF both on the tumor side and on the healthy side could be detected. The α2-MG activity did not depend on the tumor volume and clinical features. In patients with LG carcinoma with a history of more than 10 months, high values of α2-MG activity in the TF on the contralateral healthy side were detected. Conclusion. For the first time we evaluated the activity of α2-MG protein in the TF and showed characteristic features in different morphologic variants of LGT. The search for biochemical markers in TF opens new opportunities for studying the pathogenesis of this category tumors, which may contribute to the development of personalized therapy. The obtained data allow to improve diagnostics of LGT and can be applied in clinical practice in the system of complex diagnostics at the stage of preoperative preparation.
- Open Access
- 15 December 2021
- Published by Publishing House ABV Press in Advances in molecular oncology
- Vol. 8 (4)
Immunohistochemical analysis of prame expression as a prognostic factor in uveal melanoma patients
The study objective is to analyze the prognostic significance of PRAME protein expression in patients with uveal melanoma using immunohistochemical assay.Materials and methods. A total of 30 patients with uveal melanoma were examined and treated. The average age of patients at the time of treatment was 51.3 ± 11.8 years. In all cases, enucleation was performed according to the indications. A routine clinical-morphological, molecular-genetic, and immunohistochemical assay study was performed (n = 29). The immunohistochemical study was performed using antibodies to PRAME (clone 6H8, dilution 1: 50). The median follow-up period was 86.3 ± 2.9 months.Results. Of the 29 samples studied, staining was determined in 16, which was 55.2 %. Weak intensity of 1+ staining (from 10 to 20 % of tumor cells) was detected in 7 uveal melanoma samples, medium intensity of 2+ (from 10 to 20 % of tumor cells) – also in 7, and strong intensity of 3+ (30 % of tumor cells) – in 2 tumor samples. When assessing the seven-year survival, the cumulative survival rate in the group without PRAME expression was 0.857, while in the group with PRAME expression it was significantly lower and amounted to 0.357 (p = 0.0001). The PRAME protein expression was significantly correlated with the epithelioid cell type of the tumor (p = 0.041) and with the total and partial monosomy of chromosome 3 (p = 0.013).Conclusion. This paper presents the world’s first study of the prognostic significance of PRAME protein expression by immunohistochemical analysis in patients with uveal melanoma. A significant association of PRAME-positive patients with an unfavorable vital prognosis was shown.
- 15 December 2021
- Published by Publishing House ABV Press in Advances in molecular oncology
- Vol. 8 (4)
Open AccessImmunohistochemical analysis of prame expression as a prognostic factor in uveal melanoma patients
The study objective is to analyze the prognostic significance of PRAME protein expression in patients with uveal melanoma using immunohistochemical assay.Materials and methods. A total of 30 patients with uveal melanoma were examined and treated. The average age of patients at the time of treatment was 51.3 ± 11.8 years. In all cases, enucleation was performed according to the indications. A routine clinical-morphological, molecular-genetic, and immunohistochemical assay study was performed (n = 29). The immunohistochemical study was performed using antibodies to PRAME (clone 6H8, dilution 1: 50). The median follow-up period was 86.3 ± 2.9 months.Results. Of the 29 samples studied, staining was determined in 16, which was 55.2 %. Weak intensity of 1+ staining (from 10 to 20 % of tumor cells) was detected in 7 uveal melanoma samples, medium intensity of 2+ (from 10 to 20 % of tumor cells) – also in 7, and strong intensity of 3+ (30 % of tumor cells) – in 2 tumor samples. When assessing the seven-year survival, the cumulative survival rate in the group without PRAME expression was 0.857, while in the group with PRAME expression it was significantly lower and amounted to 0.357 (p = 0.0001). The PRAME protein expression was significantly correlated with the epithelioid cell type of the tumor (p = 0.041) and with the total and partial monosomy of chromosome 3 (p = 0.013).Conclusion. This paper presents the world’s first study of the prognostic significance of PRAME protein expression by immunohistochemical analysis in patients with uveal melanoma. A significant association of PRAME-positive patients with an unfavorable vital prognosis was shown.
- Open Access
- 1 January 2021
- Published by ANO NCR in Russian Electronic Journal of Radiology
- Vol. 11 (4) , 35-43
CLINICAL AND ECHOGRAPHIC FEATURES OF PATIENTS WITH VARIOUS MORPHOLOGICAL TYPES OF UVEAL MELANOMA
- 1 January 2021
- Published by ANO NCR in Russian Electronic Journal of Radiology
- Vol. 11 (4) , 35-43
Open AccessCLINICAL AND ECHOGRAPHIC FEATURES OF PATIENTS WITH VARIOUS MORPHOLOGICAL TYPES OF UVEAL MELANOMA